Bode BW - Search Results

1

Consensus Statement by the American Association of Clinical Endocrinologists/American College of Endocrinology insulin pump management task force.

Grunberger G, Abelseth JM, Bailey TS, Bode BW, Handelsman Y, Hellman R, Jovanovič L, Lane WS, Raskin P, Tamborlane WV, Rothermel C. Grunberger G, et al. Among authors: bode bw. Endocr Pract. 2014 May;20(5):463-89. doi: 10.4158/EP14145.PS. Endocr Pract. 2014. PMID: 24816754 No abstract available.

2

Insulin pump therapy in the 21st century. Strategies for successful use in adults, adolescents, and children with diabetes.

Bode BW, Tamborlane WV, Davidson PC. Bode BW, et al. Postgrad Med. 2002 May;111(5):69-77; quiz 27. doi: 10.3810/pgm.2002.05.1200. Postgrad Med. 2002. PMID: 12040864 Review.

3

Intravenous insulin infusion therapy: indications, methods, and transition to subcutaneous insulin therapy.

Bode BW, Braithwaite SS, Steed RD, Davidson PC. Bode BW, et al. Endocr Pract. 2004 Mar-Apr;10 Suppl 2:71-80. doi: 10.4158/EP.10.S2.71. Endocr Pract. 2004. PMID: 15251644 Review.

4

Switch to multiple daily injections with insulin glargine and insulin lispro from continuous subcutaneous insulin infusion with insulin lispro: a randomized, open-label study using a continuous glucose monitoring system.

Bode BW, Steed RD, Schleusener DS, Strange P. Bode BW, et al. Endocr Pract. 2005 May-Jun;11(3):157-64. doi: 10.4158/EP.11.3.157. Endocr Pract. 2005. PMID: 16239201 Clinical Trial.

5

The accuracy and efficacy of real-time continuous glucose monitoring sensor in patients with type 1 diabetes.

Mastrototaro J, Shin J, Marcus A, Sulur G; STAR 1 Clinical Trial Investigators. Mastrototaro J, et al. Diabetes Technol Ther. 2008 Oct;10(5):385-90. doi: 10.1089/dia.2007.0291. Diabetes Technol Ther. 2008. PMID: 18715215

6

Analysis of guidelines for basal-bolus insulin dosing: basal insulin, correction factor, and carbohydrate-to-insulin ratio.

Davidson PC, Hebblewhite HR, Steed RD, Bode BW. Davidson PC, et al. Among authors: bode bw. Endocr Pract. 2008 Dec;14(9):1095-101. doi: 10.4158/EP.14.9.1095. Endocr Pract. 2008. PMID: 19158048

7

Patient-reported outcomes following treatment with the human GLP-1 analogue liraglutide or glimepiride in monotherapy: results from a randomized controlled trial in patients with type 2 diabetes.

Bode BW, Testa MA, Magwire M, Hale PM, Hammer M, Blonde L, Garber A; LEAD-3 Study Group. Bode BW, et al. Diabetes Obes Metab. 2010 Jul;12(7):604-12. doi: 10.1111/j.1463-1326.2010.01196.x. Diabetes Obes Metab. 2010. PMID: 20590735 Free PMC article. Clinical Trial.

8

Insulin pump therapy in patients with type 2 diabetes safely improved glycemic control using a simple insulin dosing regimen.

Edelman SV, Bode BW, Bailey TS, Kipnes MS, Brunelle R, Chen X, Frias JP. Edelman SV, et al. Among authors: bode bw. Diabetes Technol Ther. 2010 Aug;12(8):627-33. doi: 10.1089/dia.2010.0034. Diabetes Technol Ther. 2010. PMID: 20615104 Clinical Trial.

9

Comparison of pharmacokinetic properties, physicochemical stability, and pump compatibility of 3 rapid-acting insulin analogues-aspart, lispro, and glulisine.

Bode BW. Bode BW. Endocr Pract. 2011 Mar-Apr;17(2):271-80. doi: 10.4158/EP10260.RA. Endocr Pract. 2011. PMID: 21134878 Review.

10

Statement by the American Association of Clinical Endocrinologists Consensus Panel on continuous glucose monitoring.

Blevins TC, Bode BW, Garg SK, Grunberger G, Hirsch IB, Jovanovič L, Nardacci E, Orzeck EA, Roberts VL, Tamborlane WV; AACE Continuous Glucose Monitoring Task Force; Rothermel C. Blevins TC, et al. Among authors: bode bw. Endocr Pract. 2010 Sep-Oct;16(5):730-45. doi: 10.4158/EP.16.5.730. Endocr Pract. 2010. PMID: 21356637 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

154 results

Search Page